Previous studies have proved an evidence on the interaction between FASN and the process of epithelial-mesenchymal transition (EMT) in GC [10], which reveals that FASN may be a promising therapeutic target for the anti-cancer therapy. The gene discussed is FASN; the disease is cancer.